Unknown

Dataset Information

0

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2.


ABSTRACT: The outbreak of COVID-19 has severely impacted global health and the economy. Cost-effective, highly efficacious therapeutics are urgently needed. Here, we used camelid immunization and proteomics to identify a large repertoire of highly potent neutralizing nanobodies (Nbs) to the SARS-CoV-2 spike (S) protein receptor-binding domain (RBD). We discovered multiple elite Nbs with picomolar to femtomolar affinities that inhibit viral infection at sub-ng/ml concentration, more potent than some of the best human neutralizing antibodies. We determined a crystal structure of such an elite neutralizing Nb in complex with RBD. Structural proteomics and integrative modeling revealed multiple distinct and non-overlapping epitopes and indicated an array of potential neutralization mechanisms. Structural characterization facilitated the bioengineering of novel multivalent Nb constructs into multi-epitope cocktails that achieved ultrahigh neutralization potency (IC50s as low as 0.058 ng/ml) and may prevent mutational escape. These thermostable Nbs can be rapidly produced in bulk from microbes and resist lyophilization, and aerosolization. These promising agents are readily translated into efficient, cost-effective, and convenient therapeutics to help end this once-in-a-century health crisis.

SUBMITTER: Xiang Y 

PROVIDER: S-EPMC7457627 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2.

Xiang Yufei Y   Nambulli Sham S   Xiao Zhengyun Z   Liu Heng H   Sang Zhe Z   Duprex W Paul WP   Schneidman-Duhovny Dina D   Zhang Cheng C   Shi Yi Y  

bioRxiv : the preprint server for biology 20200825


The outbreak of COVID-19 has severely impacted global health and the economy. Cost-effective, highly efficacious therapeutics are urgently needed. Here, we used camelid immunization and proteomics to identify a large repertoire of highly potent neutralizing nanobodies (Nbs) to the SARS-CoV-2 spike (S) protein receptor-binding domain (RBD). We discovered multiple elite Nbs with picomolar to femtomolar affinities that inhibit viral infection at sub-ng/ml concentration, more potent than some of the  ...[more]

Similar Datasets

| S-EPMC7857400 | biostudies-literature
| S-EPMC8126837 | biostudies-literature
| S-EPMC8420545 | biostudies-literature
| S-EPMC8907979 | biostudies-literature
| S-EPMC9529347 | biostudies-literature
| S-EPMC9869787 | biostudies-literature
| S-EPMC8356808 | biostudies-literature
| S-EPMC9258422 | biostudies-literature
| S-SCDT-EMBOR-2021-54199V1 | biostudies-other
| S-EPMC8575140 | biostudies-literature